Review
doi: 10.1016/0166-3542(92)90022-w.
Recent advances in the design of HIV proteinase inhibitors
Affiliations
- PMID: 1642479
- DOI: 10.1016/0166-3542(92)90022-w
Item in Clipboard
Review
Recent advances in the design of HIV proteinase inhibitors
Antiviral Res.
1992 Apr.
Abstract
Inhibition of HIV proteinase is currently one of the most widely studied approaches for chemotherapeutic intervention in the treatment of AIDS. A range of inhibitors of this essential enzyme has been designed from detailed knowledge of its mechanism of action and cleavage sites. These inhibitors have been classified according to their derivation. All are transition-state analogues and contain a hydroxyethylene, hydroxyethylamine, phosphinate or symmetrical moiety. Many of these inhibitors have high selectivity for the viral enzyme and significant antiviral activity. Advances in the design of HIV proteinase inhibitors that have been reported in the past year are reviewed.
Similar articles
-
Saquinavir: an HIV proteinase inhibitor.Adv Exp Med Biol. 1996;394:305-17. doi: 10.1007/978-1-4757-9209-6_28. Adv Exp Med Biol. 1996. PMID: 8815695 Review. No abstract available.
-
Inhibitors of HIV-1 proteinase containing 2-heterosubstituted 4-amino-3-hydroxy-5-phenylpentanoic acid: synthesis, enzyme inhibition, and antiviral activity.J Med Chem. 1994 Sep 16;37(19):3079-89. doi: 10.1021/jm00045a013. J Med Chem. 1994. PMID: 7932531
-
Structure-based design of sulfonamide-substituted non-peptidic HIV protease inhibitors.J Med Chem. 1995 Dec 22;38(26):4968-71. doi: 10.1021/jm00026a002. J Med Chem. 1995. PMID: 8544171 No abstract available.
-
Targeting HIV-1 protease: a test of drug-design methodologies.Trends Pharmacol Sci. 1995 Feb;16(2):67-75. doi: 10.1016/s0165-6147(00)88980-4. Trends Pharmacol Sci. 1995. PMID: 7762084 Review.
-
HIV-1 protease inhibitors: effects on HIV-2 replication and resistance.Trends Pharmacol Sci. 2008 Jan;29(1):42-9. doi: 10.1016/j.tips.2007.10.013. Epub 2007 Dec 4. Trends Pharmacol Sci. 2008. PMID: 18054799 Review.
Cited by
-
Syntheses of FDA Approved HIV Protease Inhibitors.Synthesis (Stuttg). 2001;2001(15):2203-2229. doi: 10.1055/s-2001-18434. Synthesis (Stuttg). 2001. PMID: 30393404 Free PMC article.
-
DBMAKER: a set of programs to generate three-dimensional databases based upon user-specified criteria.J Comput Aided Mol Des. 1995 Feb;9(1):65-86. doi: 10.1007/BF00117279. J Comput Aided Mol Des. 1995. PMID: 7751871
-
Potency and selectivity of inhibition of human immunodeficiency virus protease by a small nonpeptide cyclic urea, DMP 323.Antimicrob Agents Chemother. 1994 Jul;38(7):1628-34. doi: 10.1128/AAC.38.7.1628. Antimicrob Agents Chemother. 1994. PMID: 7979296 Free PMC article.
-
Protease inhibitors as antiviral agents.Clin Microbiol Rev. 1998 Oct;11(4):614-27. doi: 10.1128/CMR.11.4.614. Clin Microbiol Rev. 1998. PMID: 9767059 Free PMC article. Review.
-
Lack of immunotoxicity of saquinavir (Ro 31-8959) used alone or in double or triple combination with AZT and ddC.J Clin Immunol. 1998 Sep;18(5):346-54. doi: 10.1023/a:1023243016224. J Clin Immunol. 1998. PMID: 9793827
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
